A PHASE I STUDY OF THE COMBINATION OF AZACITIDINE AND ORAL RIGOSERTIB IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) OR ACUTE MYELOID LEUKEMIA (AML)

被引：0
|
作者：
Navada, S. C. [1 ]
Garcia-Manero, G. [2 ]
Hearn, K. [2 ]
Odchimar-Reissig, R. [1 ]
Demakos, E. [1 ]
Alvarado, Y. [2 ]
Daver, N. [2 ]
DiNardo, C. [2 ]
Konopleva, M. [2 ]
Borthakur, G. [2 ]
Azarnia, N. [3 ]
Silverman, L. R. [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, Div Hematol Oncol, New York, NY 10029 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[3] Onconova Therapeut Inc, Biometr, Newtown, PA USA
来源：
LEUKEMIA RESEARCH | 2015年 / 39卷
关键词：
D O I：
10.1016/S0145-2126(15)30090-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
89
引用
收藏
页码：S45 / S45
页数：1
相关论文
共 50 条
  • [1] A Phase I/II Study of the Combination of Oral Rigosertib and Azacitidine in Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML)
    Navada, Shyamala C.
    Garcia-Manero, Guillermo
    Wilhelm, Francois
    Hearn, Katherine
    Odchimar-Reissig, Rosalie
    Demakos, Erin P.
    Alvarado, Yesid
    Daver, Naval
    DiNardo, Courtney D.
    Konopleva, Marina
    Borthakur, Gautam
    Azarnia, Nozar
    Silverman, Lewis R.
    [J]. BLOOD, 2014, 124 (21)
  • [2] A Phase II Study of the Combination of Oral Rigosertib and Azacitidine in Patients with Myelodysplastic Syndromes (MDS)
    Navada, Shyamala C.
    Silverman, Lewis R.
    Hearn, Katherine P.
    Odchimar-Reissig, Rosalie
    Demakos, Erin P.
    Alvarado, Yesid
    Daver, Naval
    DiNardo, Courtney
    Konopleva, Marina
    Borthakur, Gautam
    Pemmaraju, Naveen
    Kadia, Tapan
    Fenaux, Pierre
    Fruchtman, Steve
    Azarnia, Nozar
    Garcia-Manero, Guillermo
    [J]. BLOOD, 2015, 126 (23)
  • [3] Rigosertib in combination with azacitidine in patients with myelodysplastic syndromes or acute myeloid leukemia: Results of a phase 1 study
    Navada, Shyamala C.
    Garcia-Manero, Guillermo
    OdchimarReissig, Rosalie
    Pemmaraju, Naveen
    Alvarado, Yesid
    Ohanian, Maro N.
    John, Rosmy B.
    Demakos, Erin P.
    Zbyszewski, Patrick S.
    Maniar, Manoj
    Woodman, Richard C.
    Fruchtman, Steven M.
    Silverman, Lewis R.
    [J]. LEUKEMIA RESEARCH, 2020, 94
  • [4] RESULTS FROM PHASE I/II STUDY OF THE COMBINATION OF ORAL RIGOSERTIB AND AZACITIDINE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    Navada, S.
    Garcia-Manero, G.
    Hearn, K.
    Odchimar-Reissig, R.
    Demakos, E.
    Alvarado, Y.
    Daver, N.
    DiNardo, C.
    Konopleva, M.
    Borthakur, G.
    Fenaux, P.
    Fruchtman, S.
    Zbyszewski, P.
    Silverman, L.
    [J]. HAEMATOLOGICA, 2016, 101 : 74 - 74
  • [5] COMBINATION OF ORAL RIGOSERTIB AND INJECTABLE AZACITIDINE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    Navada, S.
    Garcia-Manero, G.
    Hearn, K.
    Odchimar-Reissig, R.
    Demakos, E.
    Fenaux, P.
    Petrone, M.
    Zbyszewski, P.
    Fruchtman, S.
    Silverman, L.
    [J]. LEUKEMIA RESEARCH, 2017, 55 : S30 - S30
  • [6] ORAL RIGOSERTIB COMBINED WITH AZACITIDINE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) AND MYELODYSPLASTIC SYNDROMES (MDS): EFFECTS IN TREATMENT NAIVE AND RELAPSED/REFRACTORY PATIENTS
    Navada, S.
    Garcia-Manero, G.
    Hearn, K.
    Odchimar-Reissig, R.
    Demakos, E.
    Fenaux, P.
    Petrone, M.
    Zbyszewski, P.
    Fruchtman, S.
    Silverman, L.
    [J]. HAEMATOLOGICA, 2017, 102 : 183 - 184
  • [7] Combination of Oral Rigosertib and Injectable Azacitidine in Patients with Myelodysplastic Syndromes (MDS): Results from a Phase II Study
    Navada, Shyamala C.
    Garcia-Manero, Guillermo
    Hearn, Katherine P.
    Odchimar-Reissig, Rosalie
    Demakos, Erin P.
    Alvarado, Yesid
    Daver, Naval
    DiNardo, Courtney D.
    Konopleva, Marina
    Borthakur, Gautam
    Fenaux, Pierre
    Petrone, Michael E.
    Zbyszewski, Patrick Simon
    Fruchtman, Steven M.
    Silverman, Lewis R.
    [J]. BLOOD, 2016, 128 (22)
  • [8] A phase 1/2 study of rigosertib in patients with myelodysplastic syndromes (MDS) and MDS progressed to acute myeloid leukemia
    Navada, Shyamala C.
    Fruchtman, Steven M.
    Odchimar-Reissig, Rosalie
    Demakos, Erin P.
    Petrone, Michael E.
    Zbyszewski, Patrick S.
    Holland, James F.
    Silverman, Lewis R.
    [J]. LEUKEMIA RESEARCH, 2018, 64 : 10 - 16
  • [9] Comprehensive Analysis of Safety: Rigosertib in 557 Patients with Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
    Garcia-Manero, Guillermo
    Fenaux, Pierre
    Al-Kali, Aref
    Navada, Shyamala C.
    Baer, Maria R.
    Raza, Azra
    Greenberg, Peter
    Kreuzer, Karl-Anton
    Hiwase, Devendra K.
    Roboz, Gail J.
    Santini, Valeria
    Platzbecker, Uwe
    Petrone, Michael E.
    Brownstein, Bernard
    Zbyszewski, Patrick Simon
    Maniar, Manoj
    Silverman, Lewis R.
    [J]. BLOOD, 2016, 128 (22)
  • [10] Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
    Attar, Eyal C.
    Amrein, Philip C.
    Fraser, James W.
    Fathi, Amir T.
    McAfee, Steven
    Wadleigh, Martha
    DeAngelo, Daniel J.
    Steensma, David P.
    Stone, Richard M.
    Foster, Julia
    Neuberg, Donna
    Ballen, Karen K.
    [J]. LEUKEMIA RESEARCH, 2013, 37 (09) : 1016 - 1020
12345